Single-Dose Basiliximab Induction in Low-Risk Renal Transplant Recipients.

Abstract:

OBJECTIVES:To compare the efficacy of a single dose of basiliximab with two doses in preventing acute rejection in selected low-risk renal transplant recipients. METHODS:This observational study of 760 kidney transplant recipients considered to be at low immunologic risk (peak panel reactive antibody less than 10%) compared patient and graft outcomes following a single-dose versus a two-dose regimen of basiliximab. MAIN RESULTS:No differences were found in patient survival (92% vs 92%, p=0.6), graft survival (86% vs 83%, p=0.2), acute rejection (cellular [4% vs 7%, p=0.2], antibody-mediated rejection [19% vs 19%, p=0.9]), or opportunistic infections (34% vs 30%, p=0.3) between the single versus two-dose regimens, respectively. In multivariate analyses, the number of doses of basiliximab was not associated with acute rejection or patient/graft survival despite adjustment with Cox regression and propensity scores. However, delayed graft function (DGF), donor age older than 65 years, and human leukocyte antigen mismatch of 3 or higher were associated with acute rejection (hazard ratio [HR] 2.64, 1.91, and 1.57, respectively, p≤0.04), and DGF and diabetes were associated with death/graft loss (HR 2.56 and 1.63, respectively, p≤0.009). PRINCIPAL CONCLUSIONS:A single dose of basiliximab is safe and effective for induction in low-risk kidney transplant recipients.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Cunningham KC,Hager DR,Fischer J,D'Alessandro AM,Leverson GE,Kaufman DB,Djamali A

doi

10.1002/phar.1774

subject

Has Abstract

pub_date

2016-07-01 00:00:00

pages

823-9

issue

7

eissn

0277-0008

issn

1875-9114

journal_volume

36

pub_type

杂志文章
  • The use of aztreonam in pediatric patients: a review.

    abstract::Aztreonam is the first monobactam available for use in this country. A parenteral antibiotic, its antibacterial spectrum is limited to gram-negative aerobic pathogens. The drug's pharmacologic, pharmacokinetic, and toxicologic properties are reviewed. Based on early experience in pediatric patients, certain recommenda...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Bosso JA,Black PG

    更新日期:1991-01-01 00:00:00

  • Maximizing the benefit of pharmacotherapy in Parkinson's disease.

    abstract::Levodopa is one of the principal agents administered to treat patients with Parkinson's disease (PD). Several pharmacologic strategies can limit its side effects and enhance its activity. Although certain exceptions apply, dosage adjustments and drug changes should be instituted slowly. Levodopa is typically introduce...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.20.2.33s.34632

    authors: Berchou RC

    更新日期:2000-01-01 00:00:00

  • Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy.

    abstract::Neuroleptic malignant syndrome (NMS) is an idiosyncratic and uncommon but serious adverse effect that has been reported with both typical and atypical antipsychotic agents. We describe a 58-year-old man with Down syndrome and dementia who was receiving low-dose olanzapine and rivastigmine therapy; he developed NMS 4 m...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.3.403

    authors: Stevens DL,Lee MR,Padua Y

    更新日期:2008-03-01 00:00:00

  • Piperacillin-tazobactam pharmacokinetics in patients with intraabdominal infections.

    abstract:STUDY OBJECTIVE:To determine the appropriate compartmental and noncompartmental pharmacokinetic parameters for intravenous piperacillin and tazobactam. DESIGN:Sequential selection of patients entered into a randomized, open-label clinical efficacy trial. SETTING:Los Angeles County-University of Southern California Me...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Jhee SS,Kern JW,Burm JP,Yellin AE,Gill MA

    更新日期:1995-07-01 00:00:00

  • Retrospective analysis of hyperlipidemia management in a transplant population.

    abstract:STUDY OBJECTIVES:To determine the prevalence of hyperlipidemia and the effectiveness of hyperlipidemia management in a large population of transplant recipients. A secondary objective was to assess the effect of the National Cholesterol Education Program (NCEP) Adult Treatment Panel III guidelines on hyperlipidemia man...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.2005.25.7.918

    authors: Schonder KS,McKaveney TP,Lynch KJ

    更新日期:2005-07-01 00:00:00

  • Comparison of prescription drug costs in the United States and the United Kingdom, part 2: proton pump inhibitors.

    abstract:STUDY OBJECTIVE:To compare the annual cost of proton pump inhibitors (PPIs) in the United States and in the United Kingdom. DESIGN:Matched-cohort cost analysis. DATA SOURCES:U.K. General Practice Research Database (GPRD) and MarketScan Commercial Claims and Encounter Database, a large, U.S. self-insured medical claim...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/j.1875-9114.2012.01111.x

    authors: Jick H,Wilson A,Wiggins P,Chamberlain DP

    更新日期:2012-06-01 00:00:00

  • Effect of continuous arteriovenous hemodiafiltration on the pharmacokinetics of fluconazole.

    abstract::In critically ill patients with acute renal failure, continuous arteriovenous hemodiafiltration (CAVHD) has become an increasing popular supportive technique. An adult with acute renal failure during CAVHD therapy received fluconazole. Drug clearance by the hemodiafilter system and its total body clearance during the ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Nicolau DP,Crowe H,Nightingale CH,Quintiliani R

    更新日期:1994-07-01 00:00:00

  • Two-year changes in bone mineral density and T scores in patients treated at a pharmacist-run teriparatide clinic.

    abstract:STUDY OBJECTIVES:To determine changes in bone mineral density (BMD) and T scores of patients after 2 years of teriparatide therapy, and to determine the number of fractures that occurred during therapy. DESIGN:Prospective, observational study. SETTING:Pharmacist-run teriparatide clinic in a private-practice endocrino...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1592/phco.27.6.779

    authors: Stroup JS,Rivers SM,Abu-Baker AM,Kane MP

    更新日期:2007-06-01 00:00:00

  • A structured review of the relationship between microalbuminuria and cardiovascular events in patients with diabetes mellitus and hypertension.

    abstract:STUDY OBJECTIVE:To quantify the relative risk of cardiovascular events associated with microalbuminuria in patients with both diabetes mellitus and hypertension. DESIGN:A structured literature search from January 1990-December 2002 using MEDLINE, IPA, and CINAHL. MEASUREMENTS AND MAIN RESULTS:We identified original s...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.23.15.1611.31962

    authors: Park HY,Schumock GT,Pickard AS,Akhras K

    更新日期:2003-12-01 00:00:00

  • Decreased antimicrobial resistance after changes in antibiotic use.

    abstract::Vancomycin-resistant enterococci (VRE) and methicillin-oxacillin-resistant Staphylococcus aureus (MRSA) originally predominated in large medical centers; however, these isolates are now common in community hospitals and community clinics. No simple answer is available regarding control of antimicrobial-resistant bacte...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.19.12.129s.31702

    authors: Smith DW

    更新日期:1999-08-01 00:00:00

  • Important effect of food on the bioavailability of oral testosterone undecanoate.

    abstract:STUDY OBJECTIVE:To assess the effects of food on the bioavailability of testosterone undecanoate, testosterone, and 5alpha-dihydrotestosterone (DHT) after administration of a new oral testosterone undecanoate formulation, Andriol Testocaps. DESIGN:Randomized, open-label, crossover study with a 1-week washout period. ...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1592/phco.23.3.319.32104

    authors: Bagchus WM,Hust R,Maris F,Schnabel PG,Houwing NS

    更新日期:2003-03-01 00:00:00

  • Understanding and treating dyslipidemia associated with noninsulin-dependent diabetes mellitus and hypertension.

    abstract::Hypertension and diabetes appear to increase coronary heart disease risk in part by causing an abnormality in lipid metabolism. Most affected are patients with familial dyslipidemic hypertension (FDH) and noninsulin-dependent diabetes mellitus (NIDDM). The lipid disorders most often encountered in these patients are i...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: McKenney JM

    更新日期:1993-07-01 00:00:00

  • Physician-pharmacist collaborative management of asthma in primary care.

    abstract:OBJECTIVE:To determine if asthma control improves in patients who receive physician-pharmacist collaborative management (PPCM) during visits to primary care medical offices. DESIGN:Prospective pre-post study of patients who received the intervention in primary care offices for 9 months. The primary outcome was the sum...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1002/phar.1468

    authors: Gums TH,Carter BL,Milavetz G,Buys L,Rosenkrans K,Uribe L,Coffey C,MacLaughlin EJ,Young RB,Ables AZ,Patel-Shori N,Wisniewski A

    更新日期:2014-10-01 00:00:00

  • ACCP Clinical Pharmacist Competencies.

    abstract::The purpose of the American College of Clinical Pharmacy (ACCP) is to advance human health by extending the frontiers of clinical pharmacy. Consistent with this mission and its core values, ACCP is committed to ensuring that clinical pharmacists possess the knowledge, skills, attitudes, and behaviors necessary to deli...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1923

    authors: Saseen JJ,Ripley TL,Bondi D,Burke JM,Cohen LJ,McBane S,McConnell KJ,Sackey B,Sanoski C,Simonyan A,Taylor J,Vande Griend JP

    更新日期:2017-05-01 00:00:00

  • Analysis of cefepime tissue penetration into human appendix.

    abstract::Cefepime is a new extended-spectrum cephalosporin with gram-positive and gram-negative coverage including Staphylococcus aureus and Pseudomonas aeruginosa. We evaluated the drug's plasma, peritoneal fluid, and appendix tissue concentrations in patients with a postoperative diagnosis of perforated or gangrenous appendi...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Okamoto MP,Chin A,Gill MA,Yellin AE,Berne TV,Heseltine PN,Appleman MD,Knupp CA,Sclar DA

    更新日期:1991-01-01 00:00:00

  • Clinical use of anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer.

    abstract::Abstract Cetuximab and panitumumab, monoclonal antibodies used to target the epidermal growth factor receptor (EGFR), were recently approved by the United States Food and Drug Administration for use as single agents or in combination with other chemotherapy drugs in the treatment of metastatic colorectal cancer. The a...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.28.11-supp.31S

    authors: Patel DK

    更新日期:2008-11-01 00:00:00

  • Delayed elevation of international normalized ratio with concurrent clarithromycin and warfarin therapy.

    abstract::Clarithromycin is rarely reported to cause disturbances in anticoagulation. Theoretically, clarithromycin administered concurrently with warfarin could result in enhanced anticoagulation, since many properties of clarithromycin are similar to those of erythromycin, which interacts with warfarin. A search of the Nation...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Oberg KC

    更新日期:1998-03-01 00:00:00

  • Pharmacologic interventions for the management of critical bleeding.

    abstract::Hospital pharmacists are often consulted for their knowledge about coagulation and therapeutic interventions for the management of critical bleeding. Many pharmacotherapies are available for this purpose, both systemic and topical, and others are in development. These agents and their mechanisms of action are reviewed...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.27.9part2.69S

    authors: Voils S

    更新日期:2007-09-01 00:00:00

  • A Method for the 12-Hour Evaluation of Analgesic Efficacy in Outpatients with Postoperative Oral Surgery Pain: Three Studies of Diflunisal.

    abstract::We have developed a method for measuring the efficacy of a single dose of an analgesic for 12 hours after administration to outpatients with postoperative oral surgery pain. Using a self-rating record, patients evaluate their pain and its relief for 12 hours after medication. We have used this method successfully in a...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1983.3.2p2.23

    authors: Beaver WT,Forbes JA,Shackleford RW

    更新日期:1983-03-01 00:00:00

  • Tobramycin pharmacokinetics in children with febrile neutropenia undergoing stem cell transplantation: once-daily versus thrice-daily administration.

    abstract:STUDY OBJECTIVE:To describe the pharmacokinetic disposition of tobramycin in children undergoing stem cell transplantation (SCT) after intravenous administration either every 24 hours or every 8 hours, and to use this information to create initial dosing guidelines for administration every 24 hours in this patient popu...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1592/phco.24.6.564.34743

    authors: Dupuis LL,Sung L,Taylor T,Abdolell M,Allen U,Doyle J,Taddio A

    更新日期:2004-05-01 00:00:00

  • Prescribing patterns and outcomes of enoxaparin for anticoagulation of atrial fibrillation.

    abstract:STUDY OBJECTIVE:To determine prescribing patterns and clinical outcomes of enoxaparin for anticoagulation of atrial fibrillation. DESIGN:Retrospective analysis. SETTING:A 650-bed, tertiary care, community teaching hospital. SUBJECTS:Two hundred thirteen patients who received enoxaparin for thromboprophylaxis during ...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1592/phco.23.5.651.32208

    authors: Khazan M,Scheuering S,Adamson R,Mathis AS

    更新日期:2003-05-01 00:00:00

  • Changing oral contraceptives from prescription to over-the-counter status: an opinion statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy.

    abstract::Addressing the issue of unintended pregnancy is a national priority. One proposed strategy to reduce unintended pregnancy is to improve access to oral contraceptives by changing them to over-the-counter (OTC) status. Existing data indicate that oral contraceptives meet safety criteria required of OTC products. Availab...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.31.4.424

    authors: McIntosh J,Rafie S,Wasik M,McBane S,Lodise NM,El-Ibiary SY,Forinash A,Kachlic MD,Rowe E,Besinque K

    更新日期:2011-04-01 00:00:00

  • Utilization of coagulation assays in clinical therapeutics.

    abstract::With the emergence of new anticoagulants, clinicians need a thorough understanding of coagulation assays. Various laboratory assays exist to measure the effectiveness of anticoagulants. Coagulation assays are the primary method for measuring the effectiveness of anticoagulants; therefore, a comprehensive understanding...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1283

    authors: Peters GL,Erwin PB,Pitlick MK,Stacy ZA

    更新日期:2013-11-01 00:00:00

  • Comparing the bispectral index and suppression ratio with burst suppression of the electroencephalogram during pentobarbital infusions in adult intensive care patients.

    abstract:OBJECTIVE:The bispectral index (BIS), a processed variable derived from the raw electroencephalogram (EEG) used to guide sedation in the intensive care unit (ICU), has not been tested during barbiturate therapy for elevated intracranial pressure. We determined the BIS and suppression ratio (SR) values during traditiona...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.23.10.1087.32766

    authors: Riker RR,Fraser GL,Wilkins ML

    更新日期:2003-09-01 00:00:00

  • Mycobacterium szulgai in a patient with advanced acquired immunodeficiency syndrome: an unusual pathogen with unusual multidrug resistance.

    abstract::A 37-year-old Hispanic man with advanced acquired immunodeficiency syndrome developed extensive pulmonary disease with persistent cough, fever, night sweats, worsening dyspnea, and weight loss. Sputum samples showed scant growth of acid-fast bacilli. He failed to respond to the standard tuberculosis regimen of isoniaz...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.26.11.1646

    authors: Kang-Birken SL,Prichard JG

    更新日期:2006-11-01 00:00:00

  • Omadacycline Enters the Ring: A New Antimicrobial Contender.

    abstract::Omadacycline is a novel aminomethylcycline approved for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. This article reviews existing data pertaining to the biochemistry, mechanism of action, pharmacokinetics/pharmacodynamics, in vitro activity, and curre...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2185

    authors: Barber KE,Bell AM,Wingler MJB,Wagner JL,Stover KR

    更新日期:2018-12-01 00:00:00

  • Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.

    abstract::Staphylococcus aureus (S. aureus) has proven to be a major pathogen with the emergence of methicillin-resistant S. aureus (MRSA) infections and recently with heteroresistant vancomycin-intermediate S. aureus (hVISA) and vancomycin-intermediate S. aureus (VISA) infections. Although vancomycin is traditionally a first-l...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1577

    authors: Gomes DM,Ward KE,LaPlante KL

    更新日期:2015-04-01 00:00:00

  • Contrast medium-induced nephrotoxicity: pathophysiology and prevention.

    abstract::Contrast medium-induced nephrotoxicity (CMN) is a common form of iatrogenic acute renal failure. Typically, patients experience changes in serum creatinine or creatinine clearance between 1 and 5 days after exposure to a contrast medium, but they rarely require dialysis. The mechanism for CMN is not understood, but re...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.20.6.540.35154

    authors: Gerlach AT,Pickworth KK

    更新日期:2000-05-01 00:00:00

  • A pharmacoeconomic model to evaluate antibiotic costs.

    abstract:STUDY OBJECTIVES:To characterize patient sociodemographics and health, describe vancomycin treatment parameters and clinician-rated outcomes, and determine costs associated with treatment including preparation and administration, adverse events, and toxicity. DESIGN:A prospective study to develop a model for costs ass...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Garrelts JC,Horst WD,Silkey B,Gagnon S

    更新日期:1994-07-01 00:00:00

  • Resistance to antimicrobial agents: an update.

    abstract::Decades of overuse and misuse of antibiotics have turned the resistance problem into a crisis. Preventive and corrective measures are urgently needed. This article presents a broad overview of the status of antimicrobial resistance. Resistance in key bacterial pathogens such as enterococci, staphylococci, pneumococci,...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.24.18.203S.52236

    authors: Rybak MJ

    更新日期:2004-12-01 00:00:00